Compare stocks

Clariane SE is a French company specializing in care services for vulnerable individuals, operating across six European countries: France, Germany, Belgium, Italy, the Netherlands, and Spain. Its core activities are divided into three segments: long-term care, specialty care, and community care. Long-term care includes nursing homes and assisted living facilities; specialty care encompasses post-acute and rehabilitation services, mental health clinics, and home hospitalization; and community care offers shared living solutions and home care services. Founded in 2001 and formerly known as Korian, the company rebranded to Clariane SE in June 2023 and adopted the status of a purpose-driven company, emphasizing its commitment to addressing societal challenges related to aging and vulnerability. Headquartered in Paris, Clariane operates over 1,200 facilities, employing approximately 63,000 staff members. Its strategic positioning focuses on providing personalized care solutions integrated within local communities, leveraging a diversified service portfolio to meet the complex needs of an aging population. (,,)

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.